Arthritis can be managed with proper treatment.
Anticoagulation was started with intravenous unfractionated heparin for 5 days and then continued with enoxaparin.
Workup for the presence of a hypercoagulable state was negative, and the patient was anticoagulated with enoxaparin.
Docetaxel and liposomal doxorubicin chemotherapy is administered together with enoxaparin.
One woman developed a pulmonary embolus inspite of prophylaxis with enoxaparin.
The incremental cost per death averted with enoxaparin prophylaxis versus no prophylaxis was $9100.
Patients receiving dabigatran, rivaroxaban, aspirin, or no OAC pre-ablation were not bridged with enoxaparin.
The increase in hepatic enzymes during treatment with enoxaparin + dabigatran in one subject was considered moderate.
The analysis of cumulative toxicities was based on 71 (median 4/pt [range:2 4]) cycles of GFFC with enoxaparin and 108 (median 4/pt [range:0 18]) cycles of single-agent gemcitabine with enoxaparin.
No evidence of statistical heterogeneity for symptomatic venous thromboembolism was found among studies comparing rivaroxaban or apixaban with enoxaparin.
